Morgan Stanley Maintains Equal-Weight on RXO, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ravi Shanker maintains an Equal-Weight rating on RXO (NYSE:RXO) and raises the price target from $19 to $26.
August 12, 2024 | 5:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley analyst Ravi Shanker maintains an Equal-Weight rating on RXO and raises the price target from $19 to $26.
The raised price target from $19 to $26 by a reputable analyst at Morgan Stanley is likely to have a positive short-term impact on RXO's stock price as it reflects increased confidence in the company's valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100